Axsome Therapeutics Inc. (NASDAQ:AXSM) Finding Zero Support

Axsome Therapeutics Inc. (NASDAQ:AXSM) Finding Zero Support

SHARE

The Axsome Therapeutics Inc. (AXSM) shares are trading at lower $76.36 and the avg recommendation for the stock is Strong Buy.

To add more color to this target, the company’s high over the last year is $109.94 and the low is $13.64. Over the last 52 weeks, AXSM is down -30.54% while the S&P 500 is up 1.47%. The catalyst for this interesting swing was the company’s recent earnings report.

A Notable Earnings Report

In the last quarter, AXSM reported a profit of $7000.0. Axsome Therapeutics Inc. also saw revenues decrease to $32.49 million. In addition, AXSM has free cash flow of -$23.28 million as of 03-2020 The company’s EBITDA came in at -$32.31 million which compares well with its peers.

AXSM Return on Equity (ROE) is -98.60%, and its Return on Assets is -69.70%. All told, it is clear that, AXSM needs to be on your watchlist.

Find out when AXSM reaches critical levels. Subscribe to OracleDispatch.com Right Now by entering your Email in the box below.

Of course, we must look beyond the financials and question how well those numbers represent the sustainable earnings power of the business. Investors need to know how sustainable this current run. AXSM has a short ratio of 4.29 and outstanding shares of 37.06M.

Company Outlook

AXSM has seen increased volume after this news and investors are putting their support behind the value proposition. Furthermore, 10-day volume stands at 0.91 million and more growth is possible in the weeks ahead. Traders will also note the company’s earnings per share came in at -2.55. Axsome Therapeutics Inc. AXSM also noted assets of $197.8 million at the end of the last quarter. Investors should also keep an eye on sector updates as AXSM has historically followed its peers on positive news.

All told, Axsome Therapeutics Inc. AXSM has strung together solid data and demonstrated underlying fundamentals. At its current valuation, AXSM represents an interesting risk/reward case. Traders should stay tuned to see if this recent report will push the stock to test recent resistance levels.

Axsome Therapeutics Inc. AXSM is now commanding a market cap of 2.53B and a float of 28.84M. AXSM is increasing its credibility in this sector and that could lead to more upside down the line. Sign-up for continuing coverage on shares of AXSM stock, as well as other hot stock picks, get our free newsletter today and get our next breakout pick!

Disclosure: we hold no position in AXSM, either long or short, and we have not been compensated for this article.